Nexavar manufacturer?

Who Manufactures Nexavar?

Bayer Pharmaceuticals and Onyx Pharmaceuticals, which is now part of Amgen, are the co-developers of Nexavar.[1] Nexavar is used to treat certain types of cancer, including renal cell carcinoma and hepatocellular carcinoma.[2]

Manufacturing Agreement

The global development and commercialization of Nexavar is done through a collaboration between Bayer and Onyx Pharmaceuticals.[3] Under the agreement, Bayer is responsible for the majority of the sales and marketing efforts, while Onyx Pharmaceuticals contributes to the promotional efforts and manages the North American commercialization of the product.[4]

Production and Distribution

Nexavar is manufactured by various third-party manufacturers on behalf of Bayer and Onyx Pharmaceuticals, with the majority of production taking place in Europe and Asia.[5] The product is then distributed to healthcare providers and pharmacies worldwide.

Patent Information

The patent for Nexavar is held by Bayer and Onyx Pharmaceuticals.[6] However, the patent for some countries may have expired or will expire in the near future, which could allow generic versions of the product to enter the market.

References:

1. [1] drugpatentwatch.com
2. [2] FDA Approval for Nexavar
3. [3] Collaboration between Bayer and Onyx Pharmaceuticals
4. [4] Onyx Pharmaceuticals' Role in Nexavar Commercialization
5. [5] Nexavar Manufacturing Locations
6. [6] drugpatentwatch.com

Sources:

* drugpatentwatch.com
* FDA.gov: FDA Approval for Nexavar
* Bayer.com: Nexavar Partnership with Onyx Pharmaceuticals